Images and Case Reports in Arrhythmia and Electrophysiology
A 22-year-old man with a history of arrhythmogenic right ventricular (RV) cardiomyopathy with involvement of the left ventricle on noninvasive imaging, symptomatic bradycardia, and frequent ventricular ectopy underwent placement of a dual-chamber implantable cardioverter-defibrillator for the primary prevention of sudden cardiac death. The device was a model 2231-40 Fortify DR, with a model 1999 atrial lead and 7120 dual-coil RV lead (St. Jude Medical, Sylmar, CA). Device interrogation performed 1 month postimplant revealed numerous mode-switch episodes. Representative electrograms are shown in Figure 1 . Results of the interrogation also showed lead values within acceptable limits (P-wave sensing, 1.2 mV; R-wave sensing, 12 mV; pacing impedance of 350 Ω in the atrium, 490 Ω in the ventricle; high-voltage lead impedance 36 Ω; pacing thresholds of <1 V at 0.5 msec). Antibradycardia settings were programmed DDD between 50 and 150 bpm with autosensitivity programmed on in both leads (at a maximum of 0.2 mV in the atrium; 0.5 mV in the ventricle) and pacing outputs of 2.5 V at 0.5 msec. A single antitachycardia therapy zone was active for ventricular fibrillation at >200 bpm. The automatic mode switch (AMS) trigger was programmed nominally at 180 bpm. The patient had no history of atrial tachyarrhythmias before device implantation, and the electrograms were not consistent with new-onset atrial fibrillation. What is the mechanism of the inappropriate AMS episodes depicted in Figure 1 ?
Discussion
The differential diagnosis of inappropriate mode switching includes oversensing because of far-field R waves, electromagnetic interference (EMI), myopotential interference, lead/ connector problems (eg, loose set screw), or lead failure (insulation break or fracture). 1 The pacing lead impedance was stable, making a lead failure or lead/connector problem less likely, although abnormal lead measurements in these cases are often intermittent. Provocative maneuvers can be performed to unmask partial disruption in the integrity of the pace-sense circuit (a make-or-break connection). However, manual manipulation of the pocket during device interrogation in the clinic did not reproduce the stored AMS episodes.
The cause of oversensing is not apparent in Figure 1 . In fact, consideration was given to schedule the patient for an exploration of his device pocket to investigate for the possibility of a loose set screw. However, when the electrograms are displayed at higher signal gain (20 mm/mV; Figure 2 ), lowamplitude, high-frequency oscillations are noted on the atrial sensing channel, consistent with external interference. That the abnormal signal was confined to the atrial electrode and not seen on the ventricular electrode is unusual for EMI; the classic feature of EMI is that the recorded signal amplitude is greater on far-field sensing electrograms than on near-field sensing electrograms because of the wider electrode spacing on the former. In the present case, the tip-to-anode spacing of the RV electrode was 11 mm (true bipolar) and that of the atrial electrode was 1.1 mm, making it more likely for EMI to be detected on the broader antenna of the ventricular lead. Device interrogation in this patient, however, revealed no such episodes of noise/interference on the ventricular lead, and during the patient's interview, no history of exposure to unusual sources of EMI could be elicited.
Newer generation St. Jude implantable cardioverterdefibrillator platforms are equipped with an automatic multivector high-voltage lead integrity check (HVLIC) that is able to measure the high-voltage lead impedance painlessly without the need for a 12-V synchronous shock to be delivered through the lead. 2 The Current and Promote implantable cardioverter-defibrillator models conduct HVLIC every 23 hours, whereas the Unify, Fortify, Current Plus, and Promote Plus devices perform an hourly HVLIC. This feature is not programmable (K. Whitehead, BA, personal communication, St. Jude Medical, February 2012). The impedance is checked by sending a triphasic current pulse of 187.5 to 750 µA for a period of microseconds in magnitude through the electrode and performing a direct measurement of voltage between the generator and the RV coil. The high-voltage lead impedance is then calculated by Ohm's law using the voltage measurement and the known current pulse. In dual-coil devices, a similar measurement is also performed between the RV coil and the proximal coil and between the proximal coil and the generator. 3 Data from these measurements are stored and trended as part of the device diagnostics, with an alert triggered for abnormal values or sudden changes in lead impedance.
Although not previously reported, HVLIC has been recognized as a rare but potential cause of EMI (personal communication, St. Jude Medical, February 2012). In the clinic, electrogram recordings during a manual high-voltage lead impedance check reproduced the stored episodes. The higher programmed ventricular lead sensitivity may explain why the electric noise in this case was not evident on the RV sensing channel. Although this patient was asymptomatic during the AMS episodes, any cause of atrial oversensing may result in an inappropriate inhibition of pacing and may pose a risk of atrial standstill in pacemaker-dependent patients. Additionally, the inappropriate mode switch to a nontracking mode may cause symptoms related to atrioventricular asynchrony in patients prone to develop pacemaker syndrome. Figure 3 shows the AMS episode log. Episodes occurred throughout the day but remarkably always at 29 minutes past the hour. This was consistent with EMI from HVLIC and led to further investigation of the signal with changes in gain. Not every hourly impedance check generated an AMS episode because the peak amplitude of the recorded electric signal spanned the programmed atrial lead sensitivity at ≈0.2 mV. This likely also explains the variability in peak atrial rates during HVLIC noted in Figure 3 . To remedy the inappropriate AMS, the patient was brought back to the clinic for reprogramming of his atrial sensitivity from 0.2 to 0.4 mV. No further episodes were recorded on his device at follow-up.
Conclusion
We report a novel cause of electric noise recorded on the sensing electrodes of a St. Jude implantable cardioverter-defibrillator system, related to intrinsic device measurements of the highvoltage lead impedance. Although benign in most cases, reprogramming of atrial sensitivity may be required to prevent inappropriate mode switching from occurring in this setting.
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